Epigenetic markers predict complications in patients with type 2 diabetes
A new study by researchers at Lund University supports the notion that patients with type 2 diabetes patient should be divided into subgroups and given individualised treatment. The study demonstrates that there are distinct epigenetic differences between different groups of patients with type 2 diabetes. The epigenetic markers are also associated with different risks of developing common complica
https://www.lunduniversity.lu.se/article/epigenetic-markers-predict-complications-patients-type-2-diabetes - 2025-10-30
